Pfizer (PFE) Lags Q4 Earnings & Sales Estimates, Stock Down
Pfizer (PFE) Lags Q4 Earnings & Sales Estimates, Stock Down 3misses estimates for fourth-quarter earnings and sales. Loss of patent protection for key drug Lyrica in 2019 hurts sales significantly.
News story posted on 2020-01-28T18:05:00.0000000Z